Engineering of bacterial strains and vectors for the production of plasmid DNA
The demand for plasmid DNA (pDNA) is anticipated to increase significantly as DNA vaccines and non-viral gene therapies enter phase 3 clinical trials and are approved for use. This increased demand, along with renewed interest in pDNA as a therapeutic vector, has motivated research targeting the des...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
Springer Berlin Heidelberg
2009
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1721.1/49483 https://orcid.org/0000-0003-0437-3157 |